Hyperfunctioning papillary thyroid carcinoma: Clinical implications of preserved sodium/iodide symporter function
Authors:
- Xinyao LiangXLXinyao Liang
- Ningning RenNRNingning Ren
- Zhigang YaoZYZhigang Yao
- Guojun WuGWGuojun Wu
Open Access
- 9 October 2025
- journal article
- Published by Elsevier in Asian Journal of Surgery
- Vol. 49 (3) , 1727-1729
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In VivoClinical Cancer Research, 2023
- Personalized Diagnosis in Differentiated Thyroid Cancers by Molecular and Functional Imaging Biomarkers: Present and FutureDiagnostics, 2022
- Automatic differentiation of thyroid scintigram by deep convolutional neural network: a dual center studyBMC Medical Imaging, 2021
- Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NISTheranostics, 2021